Condition: Cardiogenic Shock · Heart Failure · Acute Myocardial Infarction (AMI) · Sponsor: Magenta Medical Ltd.
The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.
This description comes directly from the study's public registry record.
Yelena Lalazar Sr. Director Clinical Affairs · +972.50.6829528 · yelenal@magentamed.com
Always discuss trial participation with your own doctor first.
| Israeli-Georgian Medical Research Clinic Helsicore | Tbilisi, Georgia | Recruiting |
| Tbilisi Heart Center | Tbilisi, Georgia | Recruiting |
| Shamir Medical Center | Be’er Ya‘aqov, Israel | Recruiting |
| Rambam Medical Center | Haifa, Israel | Recruiting |
| Meir Medical Center | Kfar Saba, Israel | Recruiting |
| Beilinson Medical Center | Petah Tikva, Israel | Recruiting |
| Sheba Medical Center | Ramat Gan, Israel | Recruiting |
| Tel-Aviv Sourasky Medical Center | Tel Aviv, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07293923